Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant De-escalation, Extracapsular Spread, P16+, Transoral (ADEPT) Trial for Oropharynx Malignancy

NCT01687413 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01687413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01687413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant De-escalation, Extracapsular Spread, P16+, Transoral (ADEPT) Trial for Oropharynx Malignancy
Lead sponsor
Washington University School of Medicine
Phase
Phase 3
Overall status
Terminated
Start date
January 10, 2013
Completion date
October 18, 2019
Enrollment
42 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

oropharyngeal neoplasms